Cell and Gene Therapy Market
Cell and Gene Therapy Market
The global cell and gene therapy market size is calculated at USD 21.82 billion in 2024 and is expected to be worth USD 187.44 billion by 2034, expanding at a CAGR of 24% from 2024 to 2034, as a result of rising clinical trials and the increasing number of product approvals.
Report ID: 10047
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 21.82 Bn
Forecast Year,
USD USD 187.44 Bn
CAGR, 2025 -
24%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Cell and Gene Therapy Market Size Analysis
Cell and Gene Therapy Market Size By Therapy Type 2024 to 2034 (USD )
| Therapy Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cell Therapy | 12.00 | 14.83 | 18.59 | 22.63 | 28.79 | 34.54 | 44.58 | 52.72 | 69.03 | 80.46 | 106.89 |
| Gene Therapy | 9.82 | 12.23 | 14.96 | 18.97 | 22.80 | 29.43 | 34.74 | 45.64 | 52.93 | 70.78 | 80.64 |
Cell and Gene Therapy Market Size By Therapeutic Class 2024 to 2034 (USD )
| Therapeutic Class | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cardiovascular Disease | 1.09 | 1.34 | 1.71 | 2.01 | 2.69 | 3.03 | 4.22 | 4.55 | 6.61 | 6.84 | 10.36 |
| Cancer | 4.36 | 5.43 | 6.67 | 8.40 | 10.18 | 13.01 | 15.55 | 20.13 | 23.75 | 31.16 | 36.26 |
| Genetic Disorder | 3.27 | 4.05 | 5.06 | 6.18 | 7.84 | 9.44 | 12.12 | 14.43 | 18.75 | 22.04 | 29.01 |
| Rare Diseases | 2.18 | 2.72 | 3.31 | 4.24 | 5.03 | 6.59 | 7.64 | 10.26 | 11.60 | 15.96 | 17.61 |
| Oncology | 3.93 | 4.86 | 6.07 | 7.43 | 9.38 | 11.37 | 14.49 | 17.39 | 22.40 | 26.60 | 34.61 |
| Hematology | 2.62 | 3.26 | 3.98 | 5.07 | 6.06 | 7.88 | 9.22 | 12.23 | 14.03 | 19.00 | 21.34 |
| Ophthalmology | 1.53 | 1.88 | 2.38 | 2.85 | 3.72 | 4.31 | 5.80 | 6.53 | 9.04 | 9.88 | 14.09 |
| Infectious Disease | 1.75 | 2.18 | 2.64 | 3.40 | 4.00 | 5.31 | 6.06 | 8.28 | 9.17 | 12.92 | 13.88 |
| Neurological Disorders | 1.09 | 1.34 | 1.71 | 2.01 | 2.69 | 3.03 | 4.22 | 4.55 | 6.61 | 6.84 | 10.36 |
Cell and Gene Therapy Market Size By Delivery Method 2024 to 2034 (USD )
| Delivery Method | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| In Vivo | 13.09 | 16.19 | 20.23 | 24.77 | 31.26 | 37.90 | 48.31 | 57.98 | 74.64 | 88.70 | 115.33 |
| Ex vivo | 8.73 | 10.86 | 13.32 | 16.83 | 20.33 | 26.07 | 31.01 | 40.38 | 47.32 | 62.54 | 72.20 |
Cell and Gene Therapy Market Size By End-User 2024 to 2034 (USD )
| End-User | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 10.91 | 13.51 | 16.83 | 20.71 | 25.95 | 31.74 | 40.02 | 48.66 | 61.71 | 74.60 | 95.17 |
| Cancer Care Centers | 5.46 | 6.78 | 8.34 | 10.49 | 12.74 | 16.23 | 19.47 | 25.11 | 29.76 | 38.83 | 45.48 |
| Wound Care Centers | 2.18 | 2.69 | 3.41 | 4.07 | 5.31 | 6.16 | 8.29 | 9.32 | 12.93 | 14.10 | 20.16 |
| Others | 3.27 | 4.08 | 4.98 | 6.33 | 7.58 | 9.84 | 11.54 | 15.27 | 17.56 | 23.71 | 26.72 |
Cell and Gene Therapy Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 8.73 | 10.81 | 13.44 | 16.60 | 20.71 | 25.47 | 31.90 | 39.09 | 49.13 | 60.00 | 75.68 |
| Europe | 5.89 | 7.33 | 9.01 | 11.33 | 13.77 | 17.52 | 21.06 | 27.08 | 32.19 | 41.88 | 49.21 |
| Asia-Pacific | 5.02 | 6.21 | 7.75 | 9.51 | 11.96 | 14.56 | 18.46 | 22.30 | 28.50 | 34.15 | 43.99 |
| Latin America | 1.09 | 1.37 | 1.64 | 2.16 | 2.45 | 3.40 | 3.67 | 5.35 | 5.49 | 8.42 | 8.20 |
| Middle East & Africa | 1.09 | 1.34 | 1.72 | 2.01 | 2.70 | 3.02 | 4.24 | 4.52 | 6.65 | 6.78 | 10.44 |
Cell and Gene Therapy Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
